A 10-Week Study Evaluating the Efficacy And Safety of PD 0332334 for the Treatment of Generalized Anxiety Disorder

NCT00542685 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

551

Enrollment

INDUSTRY

Sponsor class

Conditions

Generalized Anxiety Disorder

Interventions

DRUG: PD 0332334
DRUG: Placebo
DRUG: PD 0332334
DRUG: PD 0332334

Sponsor

Pfizer